Search Results:

For decades, the public has lacked a full picture of how many animals are used in research and testing across the United States. That changed in a meaningful way this year.

In the world of IFER, we are proud to share exciting updates from graduate fellows who are receiving their degree and doing impactful work in the research field.

On May 1, NAVS welcomed supporters from across the New York City metropolitan area to a special Donor Appreciation Reception at the iconic New York Athletic Club in midtown Manhattan.

This May, NAVS proudly attended the Regeneron International Science and Engineering Fair (ISEF) in Columbus, Ohio—the world’s largest science competition for pre-college students.

We are excited to share a major step forward in the movement to end animal experimentation: The National Institutes of Health (NIH) has announced a groundbreaking initiative to reduce reliance on animals in federally funded research—and to prioritize investment in modern, human-relevant alternatives.

NAVS is proud to welcome Richard Miller, Ph.D., as a new Science Adviser and contributor to our educational and advocacy efforts.

In a significant development aligning closely with NAVS’ mission, the U.S. Food and Drug Administration (FDA) recently announced a landmark plan to phase out animal testing requirements for monoclonal antibodies and other drugs.